Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-08-002346
Filing Date
2008-02-29
Accepted
2008-02-29 15:19:49
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y50301e10vk.htm 10-K 1486101
2 EX-10.4: AMENDED AND RESTATED NON-QUALIFIED DEFERRED COMPENSATION PLAN y50301exv10w4.htm EX-10.4 85412
3 EX-10.11: AMENDED AND RESTATED EXCESS SAVINGS AND RETIREMENT PLAN y50301exv10w11.htm EX-10.11 82811
4 EX-10.31: AMENDMENT TO EMPLOYMENT AGREEMENT y50301exv10w31.htm EX-10.31 11883
5 EX-21.0: SUBSIDIARIES y50301exv21w0.htm EX-21.0 8867
6 EX-23.1: CONSENT OF DELOITTE & TOUCHE LLP y50301exv23w1.htm EX-23.1 1881
7 EX-23.2: CONSENT OF KPMG HUNGARIA KFT. y50301exv23w2.htm EX-23.2 1903
8 EX-31.1: CERTIFICATION y50301exv31w1.htm EX-31.1 8238
9 EX-31.2: CERTIFICATION y50301exv31w2.htm EX-31.2 8874
10 EX-32.0: CERTIFICATIONS y50301exv32w0.htm EX-32.0 4030
  Complete submission text file 0000950123-08-002346.txt   1701484
Mailing Address 225 SUMMIT AVE MONTVALE NJ 07645-1523
Business Address 225 SUMMIT AVE MONTVALE NJ 07645-1523 201-930-3300
BARR PHARMACEUTICALS INC (Filer) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09860 | Film No.: 08655218
SIC: 2834 Pharmaceutical Preparations